Elevated factor XI is associated with recurrent left ventricular thrombus of unknown origin
- PMID: 38465770
- DOI: 10.1111/eci.14196
Elevated factor XI is associated with recurrent left ventricular thrombus of unknown origin
Abstract
Background: Elevated factor XI (FXI) has been shown to predispose to thromboembolism. We investigated whether it is associated with left ventricular thrombus (LVT) formation, its recurrence and subsequent thromboembolic events.
Methods: In 54 patients with prior LVT of unknown origin, who stopped anticoagulation and 54 controls, we determined FXI, along with plasma clot permeability (Ks), fibrinolysis time (CLT), endogenous thrombin potential (ETP), von Willebrand factor (vWF) and fibrinolysis proteins. During follow-up, the primary endpoint involving the recurrence of LVT a symptomatic ischemic stroke or systemic embolism was recorded.
Results: Elevated (>120%) FXI levels were more often observed in LVT patients when compared to the control group (14 [25.9%] vs. 6 [11.1%], p = .048) in association with the presence of active FXI. FXI correlated with age (r = .406, p = .002), Ks (r = -.542, p < .001) and CLT (r = .406, p = .002), also after adjustment for age, but not with ETP, vWF or fibrinolysis proteins. During follow-up of 77.6 ± 18.5 months the primary endpoint occurred in 17 (31.5%) LVT patients, including 11 (20.4%) recurrent LVT, and in 4 (7.4%) controls (annual incidence rate 4.9% vs. 1.1%, respectively; p = .002). On multivariate logistic regression analysis, elevated FXI was independently associated with the primary endpoint (OR 1.18; 95% CI 1.09-1.28).
Conclusions: Elevated FXI in association with a prothrombotic state characterizes patients with prior LVT of unknown origin and predisposes to its recurrence and/or ischemic stroke during follow-up. It might be speculated that the measurement of FXI helps identify patients who could benefit from prolonged anticoagulation and FXI inhibitors in the future.
Keywords: FXI; fibrin clots; left ventricular thrombus; recurrence.
© 2024 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd.
References
REFERENCES
-
- Garber AM, Mentz RJ, Al‐Khalidi HR, et al. Clinical predictors and outcomes of patients with left ventricular thrombus following ST‐segment elevation myocardial infarction. J Thromb Thrombolysis. 2016;41(3):365‐373. doi:10.1007/s11239-015-1252-0
-
- Kurzawski J, Janion‐Sadowska A, Zandecki L, Piatek L, Koziel D, Sadowski M. Global peak left atrial longitudinal strain assessed by transthoracic echocardiography is a good predictor of left atrial appendage thrombus in patients in sinus rhythm with heart failure and very low ejection fraction—an observational study. Cardiovasc Ultrasound. 2020;18(1):7. doi:10.1186/s12947-020-00188-0
-
- Palka I, Nessler J, Nessler B, Piwowarska W, Tracz W, Undas A. Altered fibrin clot properties in patients with chronic heart failure and sinus rhythm: a novel prothrombotic mechanism. Heart. 2010;96(14):1114‐1118. doi:10.1136/hrt.2010.192740
-
- Jug B, Vene N, Salobir BG, Sebestjen M, Sabovic M, Keber I. Procoagulant state in heart failure with preserved left ventricular ejection fraction. Int Heart J. 2009;50(5):591‐600. doi:10.1536/ihj.50.591
-
- Çelik Ş, Ovali E, Baykan M, et al. Factor V Leiden and its relation to left ventricular thrombus in acute myocardial infarction. Acta Cardiol. 2001;56(1):1‐6. doi:10.2143/AC.56.1.2005587
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
